- Intent: Create an inhaler.
- Image Source: Mensgear
- Canon Link: N/A
- Permissions: N/A
- Primary Source: Airhypo | Sulfur Inhaler | Vaynai (mention of Slick's medicinal uses)
- Name: KoltAir
- Manufacturer: Delgas Medical
- Affiliation: Delgas Medical
- Market Status: Open-Market
- Modularity: No.
- Production: Minor
- Material: Kolto, Slick
- Classification: Drug
- Method of Consumption: Inhalation
- Average Life: 2 to 4 hours
- Nutritional Value/Allergies/Side Effects/ Purpose:
- Rapid delivery of food-grade quality kolto-mist to the lungs for the relief of respiratory distress,
- Supports regeneration of lung tissue; and,
- Relieves difficulty breathing.
- Immediate Relief of Respiratory Distress
- Aerosol Delivery of Regenerative Medicine To The Lungs
- Breathe Easy. KoltAir was designed to relieve the symptoms of respiratory distress, as may be caused by inhalation of smoke, toxic chemicals, or physical damage to the tissue of the lungs.
- Travel Sized For Your Convenience. Fits in your pocket.
- Mild Intoxicant. Some people or species are more sensitive to the seaweed oil in KoltAir, but drowsiness and/or mild euphoria, such as intoxication, were common side effects of its use.
- Six-Shooter. Only six doses to an airhypo, intentional to help prevent against overdoses when used regularly. That's enough to get you through one day, but what about tomorrow?
- Use Only As Directed. Exceeding the recommended dose (every 2-4 hours, no more than 6 doses in a 24-hour period) may result in adverse effects, such as nausea, dizzyness, vomiting, or hallucinations.
KoltAir was the pharmaceutical brand name for an aerosol form of Kolto treatment intended for treatment of both temporary and chronic respiratory conditions. The medical formula was a potable form of kolto that was combined with medical-quality fermented seaweed oil. The seaweed oil acted as a stimulant, providing immediate relief by opening the airways, in addition to containing regenerative properties that complimented the medicinal application of kolto to the lungs. However, as the medical oil was derived from the same source as the drug Slick, the medication carried a warning label as a mild intoxicant.
Taken as an inhaler, or airhypo, the drug was designed in small enough packaging that it could be carried in a pocket by a patient for use as needed. A typical KoltAir airhypo had approximately six doses in it, enough for one 24-hour-cycle's maximum recommended dosage. Typical doctor's orders when prescribing the use of KoltAir were to use as required; however, no more than one dose every two to hour standard hours, and no more than a maximum of six doses in a 24-hour period. Overdosing on KoltAir was not fatal, but could induce nausea, vomiting, dizzyness, or hallucinations.
Generic variations of the drug were manufactured by Chiewab Amalgamated Pharmaceuticals, SanTech, and Antilles Biogen and labeled Kolto Aerosol Treatment.
Last edited by a moderator:
